...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis and biological evaluation of new oxadiazoline-substituted naphthalenyl acetates as anticancer agents
【24h】

Synthesis and biological evaluation of new oxadiazoline-substituted naphthalenyl acetates as anticancer agents

机译:新型恶二唑啉取代的萘乙酸萘酯作为抗癌剂的合成及生物学评价

获取原文
获取原文并翻译 | 示例

摘要

A series of new oxadiazoline-substituted naphthalenyl acetates 3a-e and oxadiazoline-substituted 4-methoxynaphthalenyl acetates 7b-e were synthesized and tested by the National Cancer Institute (NCI) for their in vitro anticancer activity. The two derivatives bearing acetoxy groups at the 1 and 3 positions of the phenyl ring 3c and 7c were the most active showing significant anticancer activity against all tested cancer cell lines, with GI(50) values ranging from 0.175 to 3.91 mu M, and 0.306-11.7 mu M, respectively. The selectivity of compound 3c was greater for non-solid tumor cell lines. Computational prediction of molecular and pharmacokinetic properties revealed that both compounds are safe and compound 7c had a good drug-likeness score. (c) 2014 Elsevier Masson SAS. All rights reserved.
机译:由国家癌症研究所(NCI)合成并测试了一系列新的恶二唑啉取代的乙酸萘酯3a-e和恶二唑啉取代的4-甲氧基萘乙酸酯7b-e的体外抗癌活性。在苯环3c和7c的1和3位带有乙酰氧基的两种衍生物活性最高,对所有测试的癌细胞系均显示出显着的抗癌活性,GI(50)值范围为0.175至3.91μM和0.306 -11.7μM。化合物3c对非实体瘤细胞系的选择性更高。分子和药代动力学性质的计算预测表明,这两种化合物都是安全的,化合物7c具有良好的药物相似性评分。 (c)2014年Elsevier Masson SAS。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号